Population-Based Case-Control Study of PSA and DRE Screening on Prostate Cancer Mortality

Urology

Volumn 70, Issue 5, 2007, Pages 936-941

  Bergstralh, Eric J ^a   Roberts, Rosebud O ^a   Farmer, Sara A ^a   Slezak, Jeffrey M ^a   Lieber, Michael M ^a   Jacobsen, Steven J ^b  

^a Mayo Clinic   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CASE CONTROL STUDY; CAUSE OF DEATH; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; CASE-CONTROL STUDIES; DIGITAL RECTAL EXAMINATION; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 36549018170     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.07.009     Document Type: Article

References (22)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Roberts R.O., Bergstralh E.J., Katusic S.K., et al. Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota. J Urol 161 (1999) 529-533
3. Bill-Axelson A., Holmberg L., and Ruutu M. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352 (2005) 1977-1984
4. Messing E.M., Manola J., and Sarosdy M. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341 (1999) 1781-1788
5. Andriole G.L., Levin D.L., Crawford E.D., et al. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst 97 (2005) 433-438
6. Schroder F.H., Krause R., Rietbergen J., et al. The European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol 35 (1999) 539-543
7. Smith R.A., Cokkinides V., and Eyre J.H. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 56 (2006) 11-25
8. American Medical Association: Screening and early detection of prostate cancer. Available from: www.ama-assn.org. Accessed March 31, 2006.
9. Weiss N.S. Application of the case-control method in the evaluation of screening. Epidemiol Rev 16 (1994) 102-108
10. Jacobsen S.J., Bergstralh E.J., Katusic S.K., et al. Screening digital rectal examination and prostate cancer mortality: a population-based case-control study. Urology 52 (1998) 173-179
11. Friedman G.D., Hiatt R.A., Quesenberry Jr. C.P., et al. Case-control study of screening for prostatic cancer by digital rectal examinations. Lancet 337 (1991) 1526-1529
12. Richert-Boe K.E., Humphrey L.L., Glass A.G., et al. Screening digital rectal examination and prostate cancer mortality: a case-control study. J Med Screen 5 (1998) 99-103
13. Weinmann S., Richert-Boe K., Glass A.G., et al. Prostate cancer screening and mortality: a case-control study (United States). Cancer Causes Control 15 (2004) 133-138
14. Weinmann S., Richert-Boe K., Van den Eeden S.K., et al. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality: a case-control study. Epidemiology 16 (2005) 367-376
15. Kopec J.A., Goel G., Bunting P.S., et al. Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control study. J Urol 174 (2005) 459-499
16. Concato J., Wells C.K., Horwitz R.I., et al. The effectiveness of screening for prostate cancer: a nested case-control study. Arch Intern Med 166 (2006) 38-43
17. Melton III L.J. History of the Rochester Epidemiology Project. Mayo Clin Proc 71 (1996) 266-274
18. Bergstralh E.J., Kosanke J.L., and Jacobsen S.J. Software for optimal matching in observational studies. Epidemiology 7 (1996) 331-332
19. Hosek R.S., Flanders W.D., and Sasco A.J. Bias in case-control studies of screening effectiveness. Am J Epidemiol 143 (1996) 193-201
20. Roberts R.O., Bergstralh E.J., Besse J.A., et al. Trends and risk factors for prostate biopsy complications in the pre-PSA and PSA eras, 1980 to 1997. Urology 59 (2002) 79-84
21. Freedland SJ, and Platz EA: Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev. Epub 3 May 2007.
22. Brenner H., and Arndt V. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis. J Clin Oncol 23 (2005) 441-447